Kairos Pharma Ltd.

0.92
-0.05 (-5.15%)
At close: Mar 28, 2025, 3:59 PM
1.00
8.53%
After-hours: Mar 28, 2025, 06:45 PM EDT

Kairos Pharma Ltd. Statistics

Share Statistics

Kairos Pharma Ltd. has - shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding -
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Institutions (%) n/a
Shares Floating -
Failed to Deliver (FTD) Shares 1.25K
FTD / Avg. Volume 0.05%

Short Selling Information

The latest short interest is 9.61K, so 0.07% of the outstanding shares have been sold short.

Short Interest 9.61K
Short % of Shares Out 0.07%
Short % of Float 0.16%
Short Ratio (days to cover) 0.13

Valuation Ratios

The PE ratio is -14.9 and the forward PE ratio is -6.43. Kairos Pharma Ltd.'s PEG ratio is -0.21.

PE Ratio -14.9
Forward PE -6.43
PS Ratio 0
Forward PS null
PB Ratio -43.12
P/FCF Ratio 333.25
PEG Ratio -0.21
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Kairos Pharma Ltd..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.06, with a Debt / Equity ratio of 0.

Current Ratio 0.06
Quick Ratio 0.06
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage -17.49

Financial Efficiency

Return on equity (ROE) is 2.89% and return on capital (ROIC) is 273.8%.

Return on Equity (ROE) 2.89%
Return on Assets (ROA) -1.88%
Return on Capital (ROIC) 273.8%
Revenue Per Employee $undefined
Profits Per Employee $undefined
Employee Count undefined
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 3.08, so Kairos Pharma Ltd.'s price volatility has been higher than the market average.

Beta 3.08
52-Week Price Change null%
50-Day Moving Average 1.26
200-Day Moving Average null
Relative Strength Index (RSI) 41.06
Average Volume (20 Days) 2.43M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -1.71M
Net Income -1.81M
EBITDA -1.55M
EBIT n/a
Earnings Per Share (EPS) -0.17
Full Income Statement

Balance Sheet

The company has 93K in cash and 0 in debt, giving a net cash position of 93K.

Cash & Cash Equivalents 93K
Total Debt 0
Net Cash 93K
Retained Earnings -6.32M
Total Assets 5M
Working Capital 3.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 81K and capital expenditures 0, giving a free cash flow of 81K.

Operating Cash Flow 81K
Capital Expenditures 0
Free Cash Flow 81K
FCF Per Share 0.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KAPA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -18.68%
FCF Yield 0.65%
Dividend Details

Analyst Forecast

The average price target for KAPA is $9, which is 889% higher than the current price. The consensus rating is "Buy".

Price Target $9
Price Target Difference 889%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score 1.7
Piotroski F-Score 3